Vanessa Martins

13 papers receiving 1.3k citations

Hit Papers

Phase I Clinical Trial of a Selective Inhibitor of CYP17,...20082026201420202008200400600

Peers

Vanessa Martins
Comparison fields: 5 of 80
  • Pulmonary and Respiratory Medicine 929
  • Molecular Biology 416
  • Endocrinology, Diabetes and Metabolism 403
  • Cancer Research 331
  • Radiology, Nuclear Medicine and Imaging 236
Replace Samedy Ouk with:
Samedy Ouk United States
Edna Chow Maneval United States
Wm. Kevin Kelly United States
Teresa Wasielewska United States
Carmen A. Bañuelos Canada
Takahito Hara Japan
John E. Monahan United States
Géralyn C. Trudel United States
Andrew Kwon United States
Vanessa Martins relative to Samedy Ouk United States Samedy Ouk's profile →
Citations per field
00.5×1.5×
Samedy Ouk · 1×
Citations per year

Countries citing papers authored by Vanessa Martins

Since Specialization
Citations

This map shows the geographic impact of Vanessa Martins's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Vanessa Martins with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Vanessa Martins more than expected).

Fields of papers citing papers by Vanessa Martins

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Vanessa Martins. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Vanessa Martins. The network helps show where Vanessa Martins may publish in the future.

Co-authorship network of co-authors of Vanessa Martins

This figure shows the co-authorship network connecting the top 25 collaborators of Vanessa Martins. A scholar is included among the top collaborators of Vanessa Martins based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Vanessa Martins. Vanessa Martins is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

14 of 14 papers shown
#WorkIndexed citations
1 21
2 3
3 41
4 57
5 56
6 26
7 28
8 41
9 305
10
Phase I Clinical Trial of a Selective Inhibitor of CYP17, Abiraterone Acetate, Confirms That Castration-Resistant Prostate Cancer Commonly Remains Hormone Drivenbreakdown →
666
11
Selective inhibition of CYP17 with abiraterone acetate is well tolerated and results in a high response rate in castration-resistant prostate cancer (CRPC)
1
12
Characterization of CCT129202, a novel Aurora kinase inhibitor and in vivo quantification of biological activity
1
13 55
14
Effect of concomitant food intake on pharmacokinetics of abiraterone acetate, a 17 α hydroxylase C17,20-lyase inhibitor in castration-resistant prostate cancer (CRPC).
1

About Vanessa Martins

Vanessa Martins is a scholar working on Endocrinology, Diabetes and Metabolism, Pulmonary and Respiratory Medicine and Endocrine and Autonomic Systems, having authored 14 papers that have together received 1.3k indexed citations. Recurring topics across this work include Prostate Cancer Treatment and Research (4 papers), Hormonal and reproductive studies (3 papers) and Microtubule and mitosis dynamics (2 papers). The work is most often cited by research in Pulmonary and Respiratory Medicine (929 citations), Endocrinology, Diabetes and Metabolism (403 citations) and Cancer Research (331 citations). Vanessa Martins has collaborated with scholars based in United Kingdom, Brazil and United States. Frequent co-authors include Florence I. Raynaud, Gloria Lee, J. W. Clark, David P. Dearnaley, Colin S. Cooper, Elizabeth Folkerd, Mitch Dowsett, Stan B. Kaye, Timothy A. Yap and Mary Barrett. Their work appears in journals such as Proceedings of the National Academy of Sciences, Journal of Clinical Oncology and Journal of Medicinal Chemistry.

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026